Primco Management Inc. to Lease Space to Marijuana Retailers and Manufacturers


Follow this company

Companies Mentioned

OTC:BB:PMCM / OTC:BB:MCIG
02/13/2014 [ACCESSWIRE]

 Every day the lure of the legal-marijuana industry is attracting more companies with more propositions and new services than stadium lights attract multitudes of various species of moths.

 

Here are some of the latest entries and their products.

 

Rental Space for Marijuana Stores

 

Primco Management Inc. (OTCQB: PMCM), a multi-media entertainment and real estate development company, said that it plans to acquire properties, which it will lease to licensed retailers and manufacturers of medical marijuana.

 

In a Feb. 12, 2014 release, the Century, Calif.-based company said it plans to initially acquire property in the greater Los Angeles area with subsequent plans to extend its operations to Western States where medical marijuana is permitted by state law. The leased facilities will meet all zoning and licensing requirements for the ongoing, legal dispensing of medical cannabis. Primco will not engage in the cultivation or sale of medical cannabis or any of its byproducts.

 

“Today's political environment regarding the legalized production of medical cannabis is the solution not only for patients in need of the medicinal benefits of marijuana but also in helping to keep the illegal dealing of marijuana off the streets. The economic dynamics are perfectly aligned to make this business opportunity a great success for us,” stated Primco’s CEO David Michery, in a written statement.

PMCM’s share value closed at 17 cents on Feb 12, up 1 cent, from its close of 16 cents the previous day.  Its stock volume soared, with 302,159,168 share changing hands, nearly double its three-month average of 181,747,414 shares.

Find out what could be the best investor’s move when it comes to VAPR by getting the complete report here, or by cutting and pasting the following link in your Web browser:

http://www.sixfigurestockpicks.com

 

Wants To Market Hemp Oil in E-Cigarettes

On Feb. 6, VaporBrands International Inc. (OTC Pink: VAPR) announced that it  will market Hemp Oil produced by Marijuana, Inc. a wholly owned subsidiary of Hemp Inc., in electronic cigarettes supplied by VaporBrands for medicinal purposes and recreational use, where legal.

The two companies have formulated a strategic plan for the development of and use of Hemp Oil in specialized adaptations of VaporBrands' electronic vaporization products for use in the field of marijuana-based medicine. VaporBrands and Hemp signed a Letter of Intent on Jan. 28, 2014 with Marijuana, Inc., a wholly owned subsidiary of Hemp, Inc., a provider of products and services for the industrial hemp and medical marijuana industries.

Under the terms of the Joint Venture's strategic plan specially designed vaporizing products, including electronic cigarettes will be supplied by VaporBrands' to the Joint Venture and marketed through Medical Marijuana dispensaries and eventually retail marijuana superstores in Colorado and Washington when operational.

VaporBrands and Marijuana, Inc. have agreed to research, develop and distribute vaporizer products specifically for the use of Hemp Oil in natural medicine. Marijuana, Inc. has also agreed to assist VaporBrands in expanding the retail distribution of its current and future electronic nicotine based cigarette products.

According to the release, based on the current and projected positive market conditions for legal marijuana (medical and recreational), the Company anticipates significant demand for VaporBrands and Marijuana, Inc. co-developed vaporizing products among a wide cross-section of users that are seeking the safest and most effective way to consume marijuana.

VAPR’s share value closed at 28 cents on Feb 12, down 1 cent, from its close of 29 cents the previous day.  

Find out what could be the best investor’s move when it comes to VAPR by getting the complete report here, or by cutting and pasting the following link in your Web browser:

http://www.sixfigurestockpicks.com

 

Unveils VitaCig, Inc. – 100% Owned Subsidiary

Australian vaporizer and e-cigarette maker mCig Inc.’s (OTCQB: MCIG) is hoping that the recent  unveiling of VitaCig, Inc., mCig’s new product made by its wholly-owned subsidiary, will spur interest in the burgeoning penny stock.

Taking the same approach applied to the marijuana industry, mCig said it decided to avoid direct competition with the ultra-competitive and highly fragmented nicotine-based eCig industry. Instead, mCig decided to develop a niche product by embracing the potential of eCig technology (the ability to easily vaporize pre-packaged liquids from a pocket-sized device) as a medical delivery device.

In the fall of 2013 the company began quietly working on the new product codenamed: "Vita".

“We incorporated a new subsidiary: VitaCig, Inc. trademarked the name "VitaCig", and developed the "VitaCig" - a nicotine-free eCig that delivers a water-vapor comprised of vitamins, nutrients, and natural flavors,” mCig’s CEO Paul Rosenberg said, in a written statement.

As far as mCig is aware, a product comparable to VitaCig does not exist on the market. The company believes that VitaCig could cannibalize both the existing eCig market as well as the e-Hookah markets by providing a superior, enjoyable experience without the nicotine or overly sweet flavors. It believes the product will appeal to a wide market including: Smokers looking to quit, Smokers looking to reduce nicotine consumption, non-smokers, and rehabilitation patients suffering from illnesses.

“With the mCig we developed a brand that immediately disrupted the vaporizer market. With VitaCig we are hoping to disrupt the eCig market,” Rosenberg said. “At this stage, it would be foolish to compete head on with the major tobacco companies who are embracing electronic cigarette technology and rolling out nicotine based products,” he added.

Becoming Strong Vaporizer Player

mCig is also making an aggressive foray into the legal marijuana market by recently introducing an herb vaporizer that only retails for $10.  On Jan. 10, the company announced that it expected to fulfill all incoming orders within 5-t-10 business days with order lead time declining to 3-to-5 business days by January 21, 2014.

“Today marks an important milestone for our company. In less than six months we have transitioned from a development stage company to launching two iterations of a device that is quickly cementing itself as the most efficient and affordable way to vaporize plant material,” stated mCig, Inc. CEO Paul Rosenberg said, in a written statement.

Strategic Acquisition

On Jan. 24, mCig announced that it acquired Vapolution, Inc., an herbal vaporizer company based in Northern California in a non-dilutive transaction that consolidates an industry leader with over $1.3 million (unaudited aggregate revenue since 2010) in sales. The company contends that the acquisition transforms mCig, Inc. into a formidable competitor in two high growth categories: Personal Vaporizers (mCig 2.0, Vapolution PocketVape) and traditional home-use Vaporizers (Vapolution 2.0).

On Feb. 12, MCIG’s share price closed at 29 cents, down 2 cents from its close of 31 cents the previous day.

Find out what could be the best investor’s move when it comes to MCIGS by getting the complete report here, or by cutting and pasting the following link in your Web browser:

http://www.sixfigurestockpicks.com

 

 

Growlife Inc.’s (OTCBB: PHOT) stock volume was down  Feb. 12, 2014 with just 19,835,974, shares changing hands, only about half of its three-month average volume of 38,786,302 shares.

This comes on the heels of the company’s unexpected move to increase its authorized common stock shares by two-thirds on Feb. 7.

That’s when Growlife Inc. announced that a majority of its stockholders preliminarily approved a provision that would allow the company to increase the number of its authorized shares of common stock from 1 billion to 3 billion. 

Stock Value Increases by 11.05%

In the surprise announcement, GrowLife requested all media to accurately report that the increase is to the authorized shares, not the outstanding, and does not “immediately dilute” the current issued and outstanding share count. The company also pointed out that the provision was approved by 88.2% of the shares entitled to vote on the sole proposed item.

But so far, stockholders aren’t responding positively or negatively to the action. On Feb. 12, PHOT share price closed at 35 cents a share, up 3 cents, or 11.05%, from its close of 32 cents the previous day. 

Some industry experts contend this move gives the Woodland Hills, Calif. holding company that supplies equipment for legal marijuana growers a way to raise more money for expansion. Others are puzzled by the move and are not sure what effect it might have long term on the company’s current shareholders.

Find out what could be the best investor's move when it comes to PHOT by getting the complete report here, or by cutting and pasting the following link in your Web browser:

http://www.sixfigurestockpicks.com/

Developing Various Cannabis-Related Markets

Growlife is strongly positioning itself by developing various markets and deploying new products and services for the legal cannabis industry.

For example, one of its recently acquired companies makes hydroponic grow containers, which are designed to grow vegetables, herbs, flowers and fruits in any environment. The company appears to be vigorously considering every possible angle and service to capture its piece of the legal cannabis pie.

On Jan. 31, Growlife announced that it had entered into a strategic partnership with RXNB Inc. Growlife entered into an agreement to purchase a 40% equity stake in RXNB Inc. To sell and distribute RXNB proprietary technologies globally and share profits related to technology licensing, subject to the approval of the GrowLife board. GrowLife currently has a 45% ownership interest in OGI, with conditions under which it can gain majority interest.

RXNB is an investment company with holdings in drug formulation, manufacturing, and distribution. The company represents a recent roll-up of several independent companies in the pharmaceutical and nutraceutical market. RXNB has numerous pending patents in the field of THC research and development. RXNB has a portfolio valuation of $110 million dollars and approximately $27.5 million dollars in annual revenue.

More Information Needed

While this certainly seems like a strong positioning move by Growlife, and it's nice to know that the company it has just acquired a 40% equity share in has revenue of 27.5 million, we don't have any idea if the company has earned any profits. So again, we must wait for more thorough info before getting too excited about Growlife's latest moves.

Find out what could be the best investor's move when it comes to PHOT by getting the complete report here, or by cutting and pasting the following link in your Web browser:

http://www.sixfigurestockpicks.com/

 

ABOUT US:

Sixfigurestockpicks.com issues momentum alerts on stocks that can provide gains to day traders.

Sixfigurestockpicks.com provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more.

Sixfigurestockpicks.com  monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals DailyStockMotion.com is often in the know of several large investor awareness campaigns being deployed.

Timing is everything when trading Penny Stocks. Gain an Edge by joining the Sixfigurestockpicks.com newsletter and receiving alerts from a Pro-Active team of researchers. Trading Alerts believes traders should have a chance at successfully trading penny stocks and invites traders and investors to be part of the Free VIP membership.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.sixfigurestockpicks.com

Disclosure

Sixfigurestockpicks.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always own due diligence with any potential investment.

COMMENTS

Leave a comment...
 * 

Your Name
 *